Nature Biotechnology·· 15 小时前AI 评分4
一种为延长血浆半衰期并实现跨黏膜递送而设计的人促红细胞生成素-白蛋白融合蛋白
A human erythropoietin-albumin fusion protein tailored for enhanced plasma half-life and delivery across mucosal surfaces
AI 导读
研究报道了一种人促红细胞生成素-白蛋白融合蛋白，设计目标是延长血浆半衰期并实现跨黏膜表面递送。原文未提供临床阶段、样本量、疗效数值或监管状态等信息。
正文 · 原文
A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
来源：Nature Biotechnology · nature.com